Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	57,753	52,013	50,094	48,962	43,364	32,564
Cash & Short-Term Investments	57,753	52,013	50,094	48,962	43,364	32,564
Cash Growth	0.16%	3.83%	2.31%	12.91%	33.16%	20.59%
Accounts Receivable	2,568	2,551	3,421	2,159	1,636	1,520
Other Receivables	2,079	1,952	2,702	1,236	1,280	1,276
Receivables	4,647	4,503	6,122	3,395	2,916	7,681
Inventory	14,592	12,582	12,227	8,214	7,245	5,687
Prepaid Expenses	60.16	101.51	81.62	57.56	46.17	44.98
Other Current Assets	1,931	2,005	1,962	1,718	1,505	1,407
Total Current Assets	78,983	71,206	70,487	62,348	55,076	47,384
Property, Plant & Equipment	30,161	27,750	26,059	27,183	22,884	20,874
Long-Term Investments	36,427	33,682	25,270	22,227	17,492	13,561
Other Intangible Assets	-	0.05	0.11	-	-	-
Total Assets	145,571	132,637	121,816	111,758	95,452	81,819
Accounts Payable	1,325	1,455	1,002	625.98	666.17	553.79
Accrued Expenses	1,575	1,476	1,327	1,257	1,121	988.27
Current Portion of Long-Term Debt	620.44	614.54	618.61	200	-	-
Current Income Taxes Payable	1,275	912.27	356.1	911.5	572.68	978.04
Other Current Liabilities	10,695	823.65	926.1	666.85	818.87	721.46
Total Current Liabilities	15,491	5,282	4,229	3,662	3,179	3,242
Long-Term Debt	510.22	814.54	1,368	1,714	103.71	-
Long-Term Deferred Tax Liabilities	569.09	619.08	1,022	1,179	1,275	1,213
Total Liabilities	16,570	6,716	6,620	6,555	4,557	4,454
Common Stock	8,865	8,865	8,865	8,865	8,865	8,442
Additional Paid-In Capital	2,035	2,035	2,035	2,035	2,035	2,035
Retained Earnings	118,140	115,196	103,578	93,463	78,855	67,298
Comprehensive Income & Other	-43.3	-177.13	717.6	839.61	1,139	-410.88
Total Common Equity	128,997	125,919	115,196	105,203	90,895	77,365
Minority Interest	3.87	2.32	0.71	0.47	0.5	-
Shareholders' Equity	129,001	125,922	115,197	105,203	90,895	77,365
Total Liabilities & Equity	145,571	132,637	121,816	111,758	95,452	81,819
Total Debt	1,131	1,429	1,987	1,914	103.71	-
Net Cash (Debt)	66,453	59,877	52,697	51,395	47,885	35,256
Net Cash Growth	3.16%	13.62%	2.53%	7.33%	35.82%	17.45%
Net Cash Per Share	74.96	67.55	59.45	57.98	54.02	39.77
Filing Date Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Total Common Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Working Capital	63,492	65,924	66,258	58,686	51,898	44,143
Book Value Per Share	145.52	142.05	129.95	118.68	102.54	87.27
Tangible Book Value	128,997	125,919	115,196	105,203	90,895	77,365
Tangible Book Value Per Share	145.52	142.05	129.95	118.68	102.54	87.27
Land	-	8,486	6,632	6,446	6,136	5,711
Buildings	-	11,897	11,716	10,317	9,756	9,744
Machinery	-	30,103	29,322	26,788	25,510	24,061
Construction In Progress	5,539	1,774	1,083	6,388	2,460	724.65

Source: S&P Capital IQ. Standard template. Financial Sources.